By helping to identify newborns most at risk of brain injury in a non-invasive way, Cergenx says the device aims to enhance clinical decision-making and improve outcomes for vulnerable neonatal ...
[Image courtesy of CergenX] CergenX announced today that the FDA granted breakthrough device designation for its Wave device for neonatal brain monitoring. Additionally, the FDA accepted the Cork ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback